Citalopram Tablet
Product Images NDC 50090-5170

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 50090-5170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 01)

Chemical structure of citalopram hydrobromide, showing molecular connectivity including aromatic rings, a fluorine atom, and an amine group with methyl substituents.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 02)

A table showing the drug-placebo difference in number of cases of suicidality per 1000 patients treated by age range. It lists increases compared to placebo for under 18 and 18-24 age groups, and decreases compared to placebo for 25-64 and 65 and older age groups.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 03)

Table showing treatment-emergent adverse events incidence in placebo-controlled clinical trials for Citalopram (N=1063) compared to placebo (N=446). The table lists various body systems and related adverse events, reporting the percentage of patients experiencing each event in both groups, including autonomic, nervous, gastrointestinal, general, musculoskeletal, psychiatric, respiratory, and urogenital disorders.*

FDA Label Image

Image (D78873c1 29ce 478b Aa3d D1a11a2750ce 04)

A data table presenting adverse events associated with discontinuation of treatment in short-term, placebo-controlled depression trials comparing Citalopram and placebo. It shows the percentage of patients discontinuing due to adverse events across body systems including general, gastrointestinal, nervous system, and psychiatric disorders, with specific events like asthenia, nausea, dizziness, and insomnia.*

FDA Label Image

Label Image (Lbl500905170)

Label for Citalopram 10 mg tablets by A-S Medication Solutions. The label states the active ingredient as citalopram hydrobromide equivalent to 10 mg of citalopram, with storage instructions to keep between 68 to 77 degrees Fahrenheit. Package contains 100 oral tablets. Manufacturer noted as Invagen Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.